EDTA

Disodium EDTA in Eye Drops Preparation

September 13, 2025

Chief Pharmacist

Disodium EDTA (ethylenediaminetetraacetic acid) is often used in eye drop preparations for its chelating properties, which help to stabilize formulations ...

Disodium EDTA in Eye Drops Preparation

How to Identify Critical Material Attributes (CMAs) of an API in QbD

Extent of CMA Evaluation Required for Non-Critical Excipients

Statistics Required in Formulation Development

A Bioequivalence Lesson Experience

Do Pharmacopeial Methods Need Forced Degradation Studies?

Does f2 Apply to Modified-Release Dissolution Profiles?

Root Cause Analysis in Pharmaceutical Industry

Bound Water vs Free Water

Computer System Assurance

CSV Qualification Summary Report

Difference Between 21 CFR Part 11 and Annex 11

What is a Non-GxP System?

Determining GxP Relevant Software

Software Development Life Cycle in Pharmaceutical Industry

URS | The Foundation of CSV

Is Coning Always a Problem?

New Biosimilar Era | FDA’s Biggest Shift

Common Technical Document (CTD)

Inspection Readiness | From Audit Week to Always-On

Understanding D50 in Particle Size Distribution of API – Why It Matters!

API Particle Size Distribution (PSD) Matters in Generic Formulations

When is a Clinical Endpoint Bioequivalence Study Required?

BCS-Based Biowaiver vs. In Vivo Bioequivalence Study

Understanding Non-Sink Conditions in Dissolution Testing

Discriminatory Dissolution & Q-Point Specification – The Connection

API/Drug Substance Selection in Generic Development – Key Points

Reactive Impurities in Pharmaceutical Excipients

API Impurity Specification

Pharmacomicrobiomics

Lean Six Sigma and QbD